- Home
- CMCO vs FDMT Comparison
CMCO vs FDMT Comparison
Compare CMCO & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMCO | FDMT |
|---|---|---|
| Founded | 1875 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.1M | 513.6M |
| IPO Year | 2002 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CMCO | FDMT |
|---|---|---|
| Price | $19.08 | $9.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $21.00 | ★ $34.13 |
| AVG Volume (30 Days) | 478.9K | ★ 698.5K |
| Earning Date | 05-08-2026 | 04-13-2026 |
| Dividend Yield | ★ 1.46% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $936,240,000.00 | $37,000.00 |
| Revenue This Year | $24.92 | $21,227.03 |
| Revenue Next Year | $77.06 | $161.87 |
| P/E Ratio | $64.07 | ★ N/A |
| Revenue Growth | ★ 3.27 | N/A |
| 52 Week Low | $11.78 | $2.24 |
| 52 Week High | $24.40 | $12.34 |
Technical Indicators
Market Signals| Indicator | CMCO | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 43.00 | 57.27 |
| Support Level | $14.11 | $8.11 |
| Resistance Level | $21.58 | $9.78 |
| Average True Range (ATR) | 1.21 | 0.53 |
| MACD | -0.34 | 0.06 |
| Stochastic Oscillator | 14.94 | 59.22 |
Price Performance
Historical ComparisonAbout CMCO Columbus McKinnon Corporation
Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.